Clinical Trials

Complete Revascularization Cuts Heart Attack Mortality Risk
Research & Development Complete Revascularization Cuts Heart Attack Mortality Risk

I'm thrilled to sit down with Dr. Ivan Kairatov, a renowned interventional cardiologist and senior scientist at the Population Health Research Institute. With his extensive expertise in heart attack treatment strategies, Dr. Kairatov has been at the forefront of groundbreaking research on complete

Safer Treatment Paths for Kids with Medulloblastoma Unveiled
Research & Development Safer Treatment Paths for Kids with Medulloblastoma Unveiled

Every year, hundreds of children are diagnosed with medulloblastoma, a highly aggressive brain tumor that ranks as one of the most common malignant brain cancers in pediatric patients, leaving families grappling with not only the fear of survival but also the long-term consequences of harsh

Can New Microglia Subtype Shield Against Alzheimer’s?
Tech & Innovation Can New Microglia Subtype Shield Against Alzheimer’s?

Every day, millions of families worldwide grapple with the devastating effects of Alzheimer’s disease, a condition that robs individuals of their memories and independence, leaving loved ones searching for answers and desperate for solutions. With over 50 million people affected globally and

How Does Toddler Gut Bacteria Affect Childhood Anxiety?
Research & Development How Does Toddler Gut Bacteria Affect Childhood Anxiety?

The intricate relationship between the human gut and brain has emerged as a transformative area of study, particularly in understanding mental health challenges among children. Recent statistics reveal that anxiety disorders affect nearly one in five children, prompting researchers to explore

GLP-1 Drugs and Cancer: Risks and Protective Potential Unveiled
Research & Development GLP-1 Drugs and Cancer: Risks and Protective Potential Unveiled

In a world where obesity and type 2 diabetes affect millions, GLP-1 receptor agonists have emerged as transformative treatments, offering hope for better health outcomes. Yet, amidst their widespread adoption, a pressing concern lingers: could these powerful drugs, designed to regulate blood sugar

Sarepta DMD Drugs Fail Key Trial, Face Uncertain Future
Research & Development Sarepta DMD Drugs Fail Key Trial, Face Uncertain Future

I'm thrilled to be speaking with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the complex world of drug development for rare diseases, with a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later